Enter Your Email Address to Receive a
Copy of MedicExhange Member Demograhpics

Positron , a molecular imaging solutions company focused on Nuclear Cardiology, awarded Frost & Sullivan 2010 North American New Product Innovation Award for Attrius PET scanner

Positron Corporation is proud to announce that it is the recipient of the Frost and Sullivan 2010 North American New Product Innovation Award, for its pioneering cardiac positron emission tomography ( PET ) scanner, the Attrius.

For over 25 years, Positron has been the leader in enabling physicians to provide high quality Positron Emission Tomography, or PET, images with their proven technology. Positron offers the latest in PET cardiac imaging with the addition of the Attrius, PET scanner, to their product portfolio. The Attrius was developed to be optimized for molecular imaging of the heart, making it the ideal solution for cardiologists and hospitals looking to add high accuracy and cost effective technology. Frost & Sullivan's Best Practices Awards recognize companies in a variety of regional and global markets for demonstrating outstanding achievement and superior performance in areas such as leadership, technological innovation, customer service, and strategic product development. Industry analysts compare market participants and measure performance through in-depth interviews, analysis, and extensive secondary research in order to identify best practices in the industry. Positron is the worthy recipient of the 2010 Frost & Sullivan Award for New Product Innovation in the cardiac molecular imaging systems market. Each year, Frost & Sullivan presents this award to the company that has demonstrated superior performance against key competitors based on the following benchmarking criteria: innovative element of the product; leverage of leading edge technologies; value added features/benefits; increased customer value; and customer acquisition/penetration potential.

Joseph Oliverio, CTO of Positron Corporation stated, "We are proud that our Attrius(TM) PET scanner has been recognized by Frost and Sullivan and appreciate their team's diligence during this award process." Oliverio further states, "This is the most exciting time in the history of the Positron Corporation. The emergence of cardiac PET, as the preferred nuclear cardiology imaging modality in light of the recent SPECT reimbursement reductions and radiopharmaceutical shortages, position Positron as the only company offering a new scanner solution for the current unprecedented market demand. Positron will soon emerge as the market share leader in cardiac PET imaging."

Source: Positron